Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oncolytics Biotech Inc. ONCY

Full chart Compare
Set alert

Price alert · ONCY

All alert types
0.40 USD -0.03 (-6.07%)

Nov 5, 2026, 12:07 PM EST

0.3841 Day range 0.447
0.38 52-week range 1.30
YTD
-54.14%
1 year
-60.50%

Financial health

Altman Z-Score

-95.37 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.9×
FY 2016: -2.2×FY 2017: -6.1×FY 2018: -2.3×FY 2019: -4.1×FY 2020: -6.3×FY 2021: -3.6×FY 2022: -5.0×FY 2023: -4.4×FY 2024: -4.4×FY 2025: -2.9×
FY 2016 5y median -4.4× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -22.1×
FY 2016: 3.2×FY 2017: 11.5×FY 2018: 6.4×FY 2019: -1267×FY 2020: 4.9×FY 2021: 2.6×FY 2022: 4.8×FY 2023: 4.4×FY 2024: 16.8×FY 2025: -22.1×
FY 2016 5y median 4.4× FY 2025
P/FCF -5.7×
FY 2016: -2.7×FY 2017: -6.3×FY 2018: -3.3×FY 2019: -6.9×FY 2020: -5.5×FY 2021: -4.1×FY 2022: -7.4×FY 2023: -5.6×FY 2024: -5.0×FY 2025: -5.7×
FY 2016 5y median -5.6× FY 2025
EV/EBITDA -3.8×
FY 2016: -1.6×FY 2017: -5.6×FY 2018: -1.5×FY 2019: -6.3×FY 2020: -3.7×FY 2021: -2.1×FY 2022: -6.0×FY 2023: -3.4×FY 2024: -3.4×FY 2025: -3.8×
FY 2016 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -17.5%
FY 2016: -36.9%FY 2017: -15.8%FY 2018: -30.4%FY 2019: -14.6%FY 2020: -18.0%FY 2021: -24.2%FY 2022: -13.5%FY 2023: -17.7%FY 2024: -20.0%FY 2025: -17.5%
FY 2016 5y median -17.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 551.7%
FY 2016: -141.6%FY 2017: -188.5%FY 2018: -275.0%FY 2019: 42219.6%FY 2020: -90.9%FY 2021: -72.9%FY 2022: -69.0%FY 2023: -75.9%FY 2024: -381.0%FY 2025: 551.7%
FY 2016 5y median -72.9% FY 2025
ROIC -1250.6%
FY 2016: -143.1%FY 2017: -120.8%FY 2018: -138.3%FY 2019: -282.6%FY 2020: -79.8%FY 2021: -60.3%FY 2022: -59.0%FY 2023: -73.4%FY 2024: -185.4%FY 2025: -1250.6%
FY 2016 5y median -73.4% FY 2025
ROA -276.4%
FY 2016: -102.6%FY 2017: -86.0%FY 2018: -114.6%FY 2019: -231.7%FY 2020: -65.5%FY 2021: -57.3%FY 2022: -49.0%FY 2023: -53.9%FY 2024: -112.9%FY 2025: -276.4%
FY 2016 5y median -57.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -12.5%
FY 2016: -9.9%FY 2017: -2.0%FY 2018: -6.8%FY 2019: -20.9%FY 2020: -26.4%FY 2021: -3.0%FY 2022: 24.4%FY 2023: -28.4%FY 2024: -0.3%FY 2025: -12.5%
FY 2016 FY 2025
EPS (diluted) -36.7%
FY 2016: -3.4%FY 2017: 6.7%FY 2018: 5.4%FY 2019: -41.5%FY 2020: 68.0%FY 2021: -2.1%FY 2022: 10.2%FY 2023: 6.8%FY 2024: 26.8%FY 2025: -36.7%
FY 2016 FY 2025
Free Cash Flow -0.3%
FY 2016: 17.4%FY 2017: -20.0%FY 2018: 19.8%FY 2019: -65.6%FY 2020: -10.9%FY 2021: -2.8%FY 2022: 24.1%FY 2023: -24.4%FY 2024: 6.5%FY 2025: -0.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 3.5×FY 2017: 3.4×FY 2018: 5.1×FY 2019: 1.5×FY 2020: 12.5×FY 2021: 16.7×FY 2022: 9.0×FY 2023: 9.0×FY 2024: 2.8×FY 2025: 1.1×
FY 2016 5y median 9.0× FY 2025
Quick Ratio 1.1×
FY 2016: 3.5×FY 2017: 3.4×FY 2018: 5.1×FY 2019: 1.5×FY 2020: 12.5×FY 2021: 16.7×FY 2022: 9.0×FY 2023: 9.0×FY 2024: 2.8×FY 2025: 1.1×
FY 2016 5y median 9.0× FY 2025
Debt / Equity -0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -4.7×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.2×FY 2025: -0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.9×FY 2017: 0.8×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 1.2×FY 2021: 1.6×FY 2022: 0.6×FY 2023: 1.4×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31